Home/Filings/4/0001127602-23-012015
4//SEC Filing

Louie Ngar Yee 4

Accession 0001127602-23-012015

CIK 0001878313other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 6:32 AM ET

Size

5.1 KB

Accession

0001127602-23-012015

Insider Transaction Report

Form 4
Period: 2023-03-31
Transactions
  • Award

    Stock Options

    2023-03-31+8,5138,513 total
    Exercise: $3.46From: 2023-03-31Exp: 2033-03-31Common Stock (8,513 underlying)
Footnotes (1)
  • [F1]The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

Issuer

MAIA Biotechnology, Inc.

CIK 0001878313

Entity typeother

Related Parties

1
  • filerCIK 0001913264

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:32 AM ET
Size
5.1 KB